France proposes Resorcinol to be classified as an endocrine disruptor for human health
Ingredient: RESORCINOL

Date of publication: 20/01/2025

On January 20, 2025, the European Chemicals Agency (ECHA) received a proposal from France to classify Resorcinol as Endocrine Disruptor for human health. The proposal is open for comments until March 21 2025.

What’s new?

On January 20, 2025, the European Chemicals Agency (ECHA) received a proposal from France for a new harmonised classification and labelling for Resorcinol (CAS 108-46-3), including a classification as Endocrine Disruptor for human health and a code EUH380 (May cause endocrine disruption in humans).

Resorcinol is used in cosmetic products as an antioxidant, denaturant, hair dyeing and perfuming agent and is currently restricted in Annex III/22 to the EU Cosmetics Regulation (EC) No. 1223/2009.

This is the second time that France has submitted a dossier to classify Resorcinol as an endocrine disruptor for human health.

What now?

The proposal is open for comments until March 21 2025.

References:

European Chemicals Agency – Registry of CLH intentions until outcome – Resorcinol. January 2025

other REGULATORY UPDATES

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »

SCCS Preliminary Opinion on Sodium Bromothymol Blue (C186) as hair dyeing

Ingredients: SODIUM BROMOTHYMOL BLUE (C186)

Date of publication: 28/10/2022

Following the request from the EU Commission for a scientific opinion on the hair dye Sodium Bromothymol Blue (C186), on October 2022 the Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion. In light of the data provided, when used in non-oxidative hair colouring products up to a maximum on-head concentration of 0.5%, the SCCS is of the opinion that the complete safety of Sodium Bromothymol Blue could not be assessed.

Read More »
Any REGULATORY QUESTION?

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »